In a French hospital, a human coder might spend hours translating a patient’s chart into the precise alphanumeric codes that trigger insurance reimbursement. It is a tedious, error-prone task, and the software it runs on is often decades old, resistant to modern integration. Parallel, a Paris-based startup, is betting that the most practical path to automation is not to replace these systems, but to teach an AI to use them like a person would, clicking and typing through a virtual desktop [beparallel.com]. The company’s recently closed $20 million Series A, led by Index Ventures, is a vote of confidence that this patient, pragmatic approach can unlock efficiency in one of healthcare’s most stubborn administrative bottlenecks [Index Ventures, 2025].
The Wedge of Agentic RPA
Parallel’s core technical premise is what it calls Agentic RPA. Instead of building a complex API integration with a hospital’s legacy patient management or billing software,a process it claims can take 12 to 24 months,its AI agents operate via a remote connection that emulates mouse movements and keyboard inputs [beparallel.com]. This allows deployment in about one week, the company says, positioning the product as a swift, surgical layer atop entrenched technology. The initial and primary application is medical coding, where the AI ingests clinical notes, suggests appropriate reimbursement codes, and submits them through the existing hospital interface. For CFOs and medical directors, the promise is direct: improved coding accuracy translates to captured revenue and, the company claims, a potential 30% reduction in administrative burden [Tech Funding News, 2025].
A Team Built for the Grind
The founders bring a complementary blend of technical scale and healthcare operations experience, a combination tailored for this specific challenge. CEO Paul Lafforgue is an École Polytechnique and HEC graduate with a background in search data projects at Meta and strategy at McKinsey [Y Combinator, 2024]. His co-founder and CTO, Christopher Rydahl, previously founded Hublo, which grew into Europe’s largest healthcare staffing platform, giving him deep insight into hospital workflows and personnel pain points [beparallel.com, 2025]. They are joined by Chief Medical Officer Quentin Jarrion, a former CMIO of Ramsay Santé, France’s largest private hospital group, who provides clinical credibility and an insider’s understanding of regulatory and operational hurdles [beparallel.com, 2025].
| Role | Name | Key Background |
|---|---|---|
| Co-Founder & CEO | Paul Lafforgue | Ex-Meta (search data), ex-McKinsey, École Polytechnique/HEC [LinkedIn] [Y Combinator, 2024] |
| Co-Founder & CTO | Christopher Rydahl | Founder of Hublo (healthcare staffing platform) [Crunchbase] [beparallel.com, 2025] |
| Chief Medical Officer | Quentin Jarrion | MD, former CMIO of Ramsay Santé [LinkedIn] [beparallel.com, 2025] |
Early Traction in a Fragmented Market
Parallel is not yet a household name in digital health, but it has moved beyond theory. The company reports its AI agents are already live in dozens of public and private hospitals [Tech Funding News, 2025]. Its published case studies include partnerships with Centre Hospitalier de Dunkerque and Groupe Hospitalier Diaconesses Croix Saint-Simon in France, where the technology is being applied to streamline the coding workflow [beparallel.com]. This early, quiet traction with real institutions is a more significant signal than any press release, suggesting the product is solving a tangible, paid-for problem in a market notoriously slow to adopt new technology. The $23.5 million in total disclosed funding, following a Y Combinator batch in Winter 2024, provides a substantial runway to scale these deployments [beparallel.com, 2024] [beparallel.com, 2025].
2024 Seed | 3.5 | M USD
2025 Series A | 20 | M USD
The Skeptic’s Checklist
For all its promise, Parallel’s bet faces real-world tests that go beyond technical demonstration. The regulatory context for AI in medical coding is complex, involving compliance with data privacy laws like GDPR and ensuring audit trails for billing decisions. While the company’s agentic approach sidesteps integration headaches, it introduces other risks that must be managed.
- Accuracy and auditability. An AI making coding errors could lead to claim denials or compliance issues. The system’s performance in peer-reviewed clinical settings remains unproven, and hospitals will demand transparent logs of AI decisions.
- Scalability of emulation. Managing thousands of unique, evolving legacy software instances via remote desktop could become an operational burden, challenging the promised one-week deployment at continent-wide scale.
- Competitive landscape. While no direct competitor is named in sources, the space for AI-powered revenue cycle management is crowded with well-funded incumbents and startups. Parallel’s differentiation rests entirely on its non-integration method and European focus.
The company’s rebuttal likely lies in its team’s healthcare-specific experience and its early hospital partnerships, which serve as a live testing ground to refine the agent’s reliability and build a referenceable customer base.
For patients, the disease state here is administrative bloat, and the affected population is every person who interacts with a healthcare system. The standard of care today is a fragmented, manual process where clinical staff or specialized coders painstakingly translate narrative notes into codes across multiple outdated systems. This creates billing delays, contributes to clinician burnout, and can lead to revenue leakage for hospitals. Parallel’s ambition is to make that translation instantaneous and invisible, freeing human effort for the patient-facing work that no AI can replicate. The next twelve months will show if its agents can navigate not just the software maze, but the equally complex pathways of hospital procurement, regulation, and trust.
Sources
- [beparallel.com] Parallel Homepage | https://www.beparallel.com/
- [Y Combinator, 2024] YC Company Profile | https://www.ycombinator.com/companies/parallel
- [beparallel.com, 2024] Seed Round News | https://www.beparallel.com/news/seed-round
- [beparallel.com, 2025] Series A News | https://www.beparallel.com/news/parallel-raises-20m-to-accelerate-ai-agent-deployment-in-hospitals
- [beparallel.com] CH Dunkerque Customer Story | https://www.beparallel.com/news/customer-story-chd
- [Index Ventures, 2025] Parallel raises $20M to tackle hospital inefficiencies with AI agents | https://www.indexventures.com/perspectives/parallel-raises-20m-to-tackle-hospital-inefficiencies-with-ai-agents/
- [Tech Funding News, 2025] Paris-based Parallel raises $20M from Index Ventures to cut hospital admin by 30% with AI | https://techfundingnews.com/paris-based-parallel-raises-20m-from-index-ventures-to-cut-hospital-admin-by-30-with-ai/
- [LinkedIn] Paul Lafforgue - Parallel | https://www.linkedin.com/in/paullafforgue/
- [Crunchbase] Christopher Rydahl - Co-Founder & CTO @ Hublo | https://www.crunchbase.com/person/christopher-rydahl
- [LinkedIn] Quentin Jarrion - Works at Parallel | https://www.linkedin.com/in/quentin-jarrion/